Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 17/20 | 0.56 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.48 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24999943 | 0.83 | CYP2A6 (0.53) | APPSLC16A3APAF1USP2RAB9A | |
| SCHEMBL18154592 | 0.78 | SLC16A3 (0.57) | APPSLC16A3APAF1USP2RAB9A | |
| SCHEMBL24999944 | 0.74 | APP (0.42) | APPSLC16A3APAF1USP2RAB9A | |
| SCHEMBL24840948 | 0.74 | SLC16A3 (0.53) | APPSLC16A3APAF1USP2RAB9A | |
| SCHEMBL1803656 | 0.72 | APP (1.00) | APP | |
| SCHEMBL1803653 | 0.72 | APP (1.00) | APP | |
| SCHEMBL17768955 | 0.71 | SLC16A3 (0.61) | SLC16A3APAF1USP2RAB9AL3MBTL1 | |
| SCHEMBL1511597 | 0.71 | APP (1.00) | APP | |
| SCHEMBL1512200 | 0.71 | APP (1.00) | APP | |
| SCHEMBL1809125 | 0.71 | APP (1.00) | APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3959202-B1 | ACYL SULFONAMIDES FOR TREATING CANCER | BAYER AG (DE) | 2023-08-16 | — | — | EP | disclosed |